共 2 条
[1]
The low dose combination of fenofibrate and rosiglitazone halts the progression of diabetes-induced experimental nephropathy.[J].Mandeep Kumar Arora;Krishna Reddy;Pitchai Balakumar.European Journal of Pharmacology.2010, 1

